Tributyl(prop-2-enyl)azanium

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Tributyl(prop-2-enyl)azanium
• 化学式: C15H32N+
• 分子量: 226.42
• InChiKey: FVTLZJPHMIVATA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  16
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• IONIC LIQUID CONTAINING ALLYLSULFONATE ANION
  申请人：Watahiki Tsutomu

  公开号：US20120157680A1

  公开（公告）日：2012-06-21

  PROBLEM: Providing a novel ionic liquid, which is low-cost, environment-friendly, and has low viscosity and melting point. MEANS FOR SOLVING THE PROBLEM: The present invention is the invention of the ionic liquid represented by the general formula [1]: wherein, R 1 to R 3 and n pieces of R 4 each independently represent hydrogen atom or alkyl group having 1 to 4 carbon atoms, R 5 to R 7 each independently represent alkyl group, aralkyl group, or aryl group, R 8 represents alkyl group, aralkyl group, aryl group, or the one represented by the general formula [2]: (wherein T represents alkylene chain having 1 to 8 carbon atoms, n represents 1 or 2, and R 1 to R 7 are the same as the above-described), X represents nitrogen atom or phosphorus atom, n represents 1 or 2. When n is 1, R 3 and R 4 are bound and may form cyclohexene ring together with the adjacent carbon atoms. In addition, when X is nitrogen atom, R 5 to R 7 or R 5 to R 6 may form hetero ring with nitrogen atom binding thereto}.

  问题：提供一种新型离子液体，成本低、环保，并具有低粘度和熔点。 解决问题的方法：本发明是一种由通式[1]表示的离子液体的发明：其中，R1到R3和n个R4分别独立表示氢原子或具有1到4个碳原子的烷基基团，R5到R7分别独立表示烷基基团、芳基烷基基团或芳基基团，R8表示烷基基团、芳基烷基基团、芳基基团或由通式[2]表示的基团：（其中T表示具有1到8个碳原子的烷基链，n表示1或2，R1到R7与上述相同），X表示氮原子或磷原子，n表示1或2。当n为1时，R3和R4结合并且可能与相邻碳原子一起形成环己烯环。此外，当X为氮原子时，R5到R7或R5到R6可能与结合在一起的氮原子形成杂环}。
• Neuroprotection by positively-charged nitroxides
  申请人：Balaraman Kalyanaraman

  公开号：US20070066572A1

  公开（公告）日：2007-03-22

  Methods for treating neurodegenerative disorders characterized by abnormal reactive oxygen species including administering to a subject an effective amount of a mitochondria-targeted nitroxide. Likewise, methods for mitigating reactive-oxygen species-mediated apoptosis including administering an effective amount of a mitochondria-targeted nitroxide.

  治疗神经退行性疾病的方法，其特征是异常的活性氧种类，包括向受试者施用有效量的线粒体靶向亚硝酰基。同样，减轻活性氧种类介导的凋亡的方法，包括向受试者施用有效量的线粒体靶向亚硝酰基。
• PREPARATION OF NORMORPHINANS
  申请人：Mallinckrodt LLC

  公开号：US20150141649A1

  公开（公告）日：2015-05-21

  The present invention provides processes for preparing normorphinans from N-substituted morphinans. In particular, the invention provides methods for removing the N-substituent from the N-substituted morphinan to from a normorphinan carbamate, and then removing the carbamate functionality from the normorphinan carbamate to form the normorphinan.

  本发明提供了从N-取代吗啡内酯制备正吗啡内酯的方法。具体而言，本发明提供了从N-取代吗啡内酯中去除N-取代基，形成正吗啡内酯羰酸酯的方法，然后去除正吗啡内酯羰酸酯中的羰酸酯功能团，形成正吗啡内酯的方法。
• In Vivo Mitochondrial Labeling Using Positively-Charged Nitroxide Enhanced and Gadolinium Chelate Enhanced Magnetic Resonance Imaging
  申请人：Kalyanaraman Balaraman

  公开号：US20090214437A1

  公开（公告）日：2009-08-27

  A system and method for acquiring MR imaging data from a subject includes administering positively-charged nitroxides or gadolinium chelates for in vivo mitochondrial labeling, acquiring MR imaging data from the subject, and reconstructing an image of the subject having enhanced contrast in areas including metabolic and/or mitotic activity.

  一种从被试体内采集MR成像数据的系统和方法，包括给予带正电荷的亚硝基或钆螯合物进行体内线粒体标记，从被试体内采集MR成像数据，并重建一幅被试体的图像，其中包括代谢和/或有丝分裂活动区域增强对比度。
• [EN] PREPARATION OF NORMORPHINANS<br/>[FR] PRÉPARATION DE NORMORPHINANES
  申请人：MALLINCKRODT LLC

  公开号：WO2015074049A1

  公开（公告）日：2015-05-21

  The present invention provides processes for preparing normorphinans from N-substituted morphinans. In particular, the invention provides methods for removing the N-substituent from the N-substituted morphinan to from a normorphinan carbamate, and then removing the carbamate functionality from the normorphinan carbamate to form the normorphinan.

  本发明提供了从N-取代吗啡酮制备正吗啡的过程。特别地，本发明提供了从N-取代吗啡酮中去除N-取代基，形成正吗啡氨甲酸酯的方法，然后从正吗啡氨甲酸酯中去除氨甲酸酯官能团，形成正吗啡的方法。